Editorial & Opinion
Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.
العنوان: | Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia. |
---|---|
المؤلفون: | Santos FM; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Ghelfond G; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Seguro FS; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Abdo ANR; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Dalessandro T; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Maciel FVR; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Bassolli L; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Rocha V; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Churchill Hospital, Oxford University, Oxford, UK., Bendit I; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil. |
المصدر: | American journal of hematology [Am J Hematol] 2022 Feb 01; Vol. 97 (2), pp. E72-E74. Date of Electronic Publication: 2021 Nov 30. |
نوع المنشور: | Letter |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
أسماء مطبوعة: | Publication: New York Ny : Wiley-Blackwell Original Publication: New York, Liss. |
مواضيع طبية MeSH: | Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*complications , Pregnancy Complications, Neoplastic/*etiology, Adult ; Antineoplastic Agents/therapeutic use ; Female ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy ; Pregnancy ; Pregnancy Complications, Neoplastic/drug therapy ; Pregnancy Outcome ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Young Adult |
References: | Lasica M, Willcox A, Burbury K, et al. The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia. Leuk Lymphoma. 2019;60(7):1796-1802. doi:10.1080/10428194.2018.1551533. Chen TC, Chen LC, Bin HY, Chang CS. Imatinib adherence associated clinical outcomes of chronic myeloid leukaemia treatment in Taiwan. Int J Clin Pharm. 2014;36(1):172-181. doi:10.1007/s11096-013-9876-7. Abruzzese E, Elena C, Castagnetti F, Gambacorti-Passerini C, Annunziata M, Luciano LM. Gimema registry of conception/pregnancy in adult Italian patients diagnosed with chronic myeloid leukemia (CML): report on 166 outcomes. Blood. 2018;132(supp 1):43. doi:10.1182/blood-2018-99-118908. Prager S, Dalton VK, Allen R. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2018;132(5):e197-e207. Cole S, Kantarjian H, Ault P, Cortés JE. Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature. Clin Lymphoma Myeloma. 2009;9(4):324-327. doi:10.3816/CLM.2009.n.064. Rankin J, Pattenden S, Abramsky L, et al. Prevalence of congenital anomalies in five British regions, 1991-99. Arch Dis Child Fetal Neonatal Ed. 2005;90(5):374-379. doi:10.1136/adc.2003.047902. |
المشرفين على المادة: | 0 (Antineoplastic Agents) 0 (Protein Kinase Inhibitors) |
تواريخ الأحداث: | Date Created: 20211125 Date Completed: 20220209 Latest Revision: 20220209 |
رمز التحديث: | 20231215 |
DOI: | 10.1002/ajh.26424 |
PMID: | 34822180 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1096-8652 |
---|---|
DOI: | 10.1002/ajh.26424 |